Abstract
BackgroundSystemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease characterized by a relapsing-remitting course. Long-term prognosis of SLE patients remains poor [1]. Due to the effect of potent anti-inflammatory...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have